Klimek, LudgerPrice, DavidGalffy, G.Emmeluth, M.Koltun, A.Kopietz, F.Nguyen , D.TVan Weissenbruch, R.Pohl, WKuhl, H. C.Scadding, G.Mullol, J.2021-03-232021-03-232020-10-01Klimek, L, Price, D, Galffy, G, Emmeluth, M, Koltun, A, Kopietz, F, Nguyen , D T, Van Weissenbruch, R, Pohl, W, Kuhl, H C, Scadding, G & Mullol, J 2020, 'Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study', International Archives of Allergy and Immunology, vol. 181, no. 10, pp. 754-764. https://doi.org/10.1159/0005087491018-2438https://hdl.handle.net/2164/16112Acknowledgements: We would like to thank the subjects who participated in the trial. Funding Sources: This study was supported by MEDA Pharma GmbH & Co. KG (a Mylan Company), Bad Homburg, Germany. Technical, editorial, and medical writing assistance were provided under the direction of the authors by Strategix, an affiliate of The Lynx Group, LLC. This assistance was supported by MEDA Pharma GmbH & Co. KG (a Mylan Company).11473561engAllergic rhinitisAllergic rhinitis phenotypeComorbiditiesImmunoglobulin E responseVisual analog scaleR MedicineImmunology and AllergyImmunologyRJournal article10.1159/000508749http://www.scopus.com/inward/record.url?scp=85092681822&partnerID=8YFLogxK18110